Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$23.16 USD
+0.12 (0.52%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $23.63 +0.47 (2.03%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Bicycle Therapeutics PLC Sponsored ADR [BCYC]
Reports for Purchase
Showing records 21 - 40 ( 101 total )
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
2Q22: Clinical Programs Progress-Data from Two Programs Later in 2022
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
1Q22: Additional Clinical Data from Two Programs in 2022
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Unwarranted BT8009 AACR Roller-coaster; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Tumor Control in More Cancers with Nectin-4 Drug at AACR
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
AACR 2022 Abstract Titles Released: BCYC CRSP GTBP PBLA TCRR
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Looking into 1Q22, Cash Balance, & Price Target Changes
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Biotechnology-Looking into 1Q22, Cash Balance, & Price Target Changes
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Clinical Updates and a New Program Enters the Clinic
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T